ArticleKidney medicine2025

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors: A Novel Therapy in the Treatment of Cholesterol Crystal Embolism-Induced Kidney Injury.

Benjamin J Strimaitis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.